DK2538986T3 - Intraartikulært supplement til anvendelse til behandling af ledsygdomme og -skader - Google Patents

Intraartikulært supplement til anvendelse til behandling af ledsygdomme og -skader Download PDF

Info

Publication number
DK2538986T3
DK2538986T3 DK11702660T DK11702660T DK2538986T3 DK 2538986 T3 DK2538986 T3 DK 2538986T3 DK 11702660 T DK11702660 T DK 11702660T DK 11702660 T DK11702660 T DK 11702660T DK 2538986 T3 DK2538986 T3 DK 2538986T3
Authority
DK
Denmark
Prior art keywords
intraarticular
injuries
supplement
diseases
led
Prior art date
Application number
DK11702660T
Other languages
English (en)
Inventor
Yves Henrotin
Christelle Sanchez
Frédéric Oprenyeszk
Pierre Drion
Original Assignee
Université de Liège
Kitozyme S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Université de Liège, Kitozyme S A filed Critical Université de Liège
Application granted granted Critical
Publication of DK2538986T3 publication Critical patent/DK2538986T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/734—Alginic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/26—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3817—Cartilage-forming cells, e.g. pre-chondrocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/06—Materials or treatment for tissue regeneration for cartilage reconstruction, e.g. meniscus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Dispersion Chemistry (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Anesthesiology (AREA)
  • Nutrition Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Obesity (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
DK11702660T 2010-02-25 2011-02-11 Intraartikulært supplement til anvendelse til behandling af ledsygdomme og -skader DK2538986T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10154712A EP2361640A1 (en) 2010-02-25 2010-02-25 Cell cultivation in chitosan alginate hydrogel beads
PCT/EP2011/052020 WO2011104133A1 (en) 2010-02-25 2011-02-11 An intra-articular supplementation method for treating joint diseases and injuries

Publications (1)

Publication Number Publication Date
DK2538986T3 true DK2538986T3 (da) 2015-03-02

Family

ID=42308548

Family Applications (2)

Application Number Title Priority Date Filing Date
DK11702660T DK2538986T3 (da) 2010-02-25 2011-02-11 Intraartikulært supplement til anvendelse til behandling af ledsygdomme og -skader
DK11703452.0T DK2538987T3 (da) 2010-02-25 2011-02-11 Celledyrkning i chitosanalginat-hydrogelperler

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK11703452.0T DK2538987T3 (da) 2010-02-25 2011-02-11 Celledyrkning i chitosanalginat-hydrogelperler

Country Status (10)

Country Link
US (4) US8883733B2 (da)
EP (3) EP2361640A1 (da)
JP (2) JP5208332B2 (da)
KR (2) KR101863533B1 (da)
CN (2) CN102762233B (da)
DK (2) DK2538986T3 (da)
ES (2) ES2531066T3 (da)
PL (2) PL2538986T3 (da)
SG (2) SG183380A1 (da)
WO (2) WO2011104131A1 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010033726A2 (en) 2008-09-17 2010-03-25 The Brigham And Women's Hospital, Inc. Drug delivery composition comprising a self-assembled gelator
JP2013540757A (ja) 2010-09-24 2013-11-07 ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッド カプセル化された作用物質の放出を制御する能力を有するナノ構造ゲル
WO2015187862A1 (en) * 2014-06-04 2015-12-10 Likarda, LLC Microencapsulation technique and products thereof
FR3024362A1 (fr) 2014-08-01 2016-02-05 Synolyne Pharma Sa Composition thermogelifiable sterilisee
FR3029116B1 (fr) 2014-12-01 2018-03-30 Advanced Chitosan Solutions Biotech Procede d'obtention d'un gel de cartilage pour la reparation cartilagineuse, comprenant du chitosane et des chondrocytes
FR3029422B1 (fr) * 2014-12-05 2017-01-13 Synolyne Pharma Microbille d'hydrogel
FR3029790B1 (fr) * 2014-12-12 2017-01-13 Synolyne Pharma Microbille d'hydrogel de chitosane
EP3359128A1 (en) 2015-10-08 2018-08-15 The Brigham and Women's Hospital, Inc. Stabilized assembled nanostructures for delivery of encapsulated agents
US10568840B2 (en) 2016-05-06 2020-02-25 The Brigham And Women's Hospital, Inc. Self assembled gels for controlled delivery of encapsulated agents to cartilage
WO2018144991A1 (en) 2017-02-03 2018-08-09 The Brigham And Women's Hospital, Inc. Self-assembled gels formed with anti-retroviral drugs, prodrugs thereof, and pharmaceutical uses thereof
EP3621594A1 (en) 2017-05-08 2020-03-18 Alivio Therapeutics, Inc. Formulation of nanostructured gels for increased agent loading and adhesion
CA3113948A1 (en) 2018-10-11 2020-04-16 Alivio Therapeutics, Inc. Non-injectable hydrogel formulations for smart release
CN109251887A (zh) * 2018-10-12 2019-01-22 山东麦德克斯生物科技有限公司 一种软骨细胞引物层的制备方法及软骨组织
JP7638529B2 (ja) 2019-03-21 2025-03-04 アンテロジェン シーオー．，エルティーディー． 間葉系幹細胞－ヒドロゲルを含有する注射用組成物、並びにその製造、凍結及び解凍方法
JP2023513919A (ja) * 2020-02-14 2023-04-04 コルトン、ウィリアム バクテリオファージカクテル含有ハイドロゲル組成物並びにその製造及び使用方法
CN112481134B (zh) * 2020-11-26 2022-03-18 浙江工业大学 一种利用微生物发酵法提取桑叶多糖的方法
KR102882681B1 (ko) * 2022-06-15 2025-11-11 (주)바이오트코리아 자기구동이 가능한 치료물질 전달용 하이드로겔 마이크로비즈의 제조방법, 이에 의해 제조된 하이드로겔 마이크로비즈 및 이를 포함하는 근골격계 질환 치료용 약학 조성물
KR102946522B1 (ko) 2023-08-08 2026-04-01 주식회사 엔도비전 석류 추출물 함유 다당류 기반 하이드로젤 주사제 및 지혈제

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2327074B (en) * 1997-07-07 2001-09-12 Norsk Hydro As Improvements in or relating to capsules
KR100880622B1 (ko) * 2000-06-29 2009-01-30 바이오신텍 캐나다 인코포레이티드 연골 및 다른 조직의 복구 및 재생용 조성물 및 방법
FR2819814B1 (fr) * 2001-01-22 2004-10-29 Tbf Lab Composition gelifiable biocompatible et implantable
CN1299653C (zh) * 2004-02-12 2007-02-14 上海大学 仿生人工关节囊及其制备方法
US7767656B2 (en) * 2005-04-25 2010-08-03 Molly S Shoichet Blends of temperature sensitive and anionic polymers for drug delivery
CN100381568C (zh) * 2005-04-27 2008-04-16 中国科学院沈阳应用生态研究所 一种生物微胶囊化的方法
ITPD20060203A1 (it) * 2006-05-22 2007-11-23 Univ Degli Studi Trieste Idrogeli di miscele di polisaccaridi per l'ingegneria tissutale e la veicolazione di composti attivi
ITMI20061726A1 (it) * 2006-09-11 2008-03-12 Fidia Farmaceutici Derivati crosslinkati a base di acido ialuronico reticolato via click chemistry
CN101285053A (zh) * 2008-05-28 2008-10-15 大连理工大学 一种动态悬浮条件下共同培养脐血造血干细胞与间充质干细胞的方法

Also Published As

Publication number Publication date
SG183380A1 (en) 2012-09-27
EP2361640A1 (en) 2011-08-31
EP2538986B1 (en) 2014-12-03
PL2538986T3 (pl) 2015-05-29
CN102762233A (zh) 2012-10-31
CN102753205A (zh) 2012-10-24
DK2538987T3 (da) 2014-12-08
US9480648B2 (en) 2016-11-01
EP2538987A1 (en) 2013-01-02
JP2013520188A (ja) 2013-06-06
SG183379A1 (en) 2012-09-27
US20150056266A1 (en) 2015-02-26
JP2013520258A (ja) 2013-06-06
KR20130027470A (ko) 2013-03-15
US9561180B2 (en) 2017-02-07
WO2011104131A1 (en) 2011-09-01
KR101740298B1 (ko) 2017-05-26
EP2538986A1 (en) 2013-01-02
US20150072013A1 (en) 2015-03-12
PL2538987T3 (pl) 2015-04-30
US8889158B2 (en) 2014-11-18
JP5208332B2 (ja) 2013-06-12
CN102762233B (zh) 2016-02-24
EP2538987B1 (en) 2014-09-24
US8883733B2 (en) 2014-11-11
US20120321678A1 (en) 2012-12-20
US20120315307A1 (en) 2012-12-13
ES2531066T3 (es) 2015-03-10
JP5270803B2 (ja) 2013-08-21
WO2011104133A1 (en) 2011-09-01
KR20130020769A (ko) 2013-02-28
KR101863533B1 (ko) 2018-06-04
ES2526592T3 (es) 2015-01-13
CN102753205B (zh) 2016-02-10

Similar Documents

Publication Publication Date Title
DK2538986T3 (da) Intraartikulært supplement til anvendelse til behandling af ledsygdomme og -skader
IL271083A (en) Humanized fcgammar mice
EP2621499A4 (en) METHODS OF TREATING ALLERGIC DISEASES
DK2919796T3 (da) Brug af akkermansia til behandling af stofskiftesygdomme
PT2448582T (pt) Compostos e composições terapêuticas
ZA201301601B (en) Treatment of diseases
HUE037600T2 (hu) Vegyületek és készítmények paraziták által okozott fertõzések kezelésére
PL2496691T3 (pl) Terapeutyczne kompozycje nukleazy i sposoby
DK3124610T3 (da) Hbv-behandling
EP2555765A4 (en) TREATMENT OF LOUIS BAR SYNDROME
EP2442821A4 (en) SAFE ADMINISTRATION OF DESMOPRESSIN
DK2747763T3 (da) (bacterio-)chlorofyllfotosensibilisatorer til behandling af øjensygdomme og -lidelser
LT3292875T (lt) Kompozicijos ir būdai, skirti ligų gydymui
PL2582366T3 (pl) Kombinacja farmaceutyczna do leczenia bólu
PL2435825T3 (pl) Sposoby leczenia chorób
DK2627345T3 (da) Formuleringer til behandling af sygdomme i de øvre luftveje
IL229858B (en) Polypeptides and uses thereof for tratment of autoimmune disorders and infection
PL2718434T3 (pl) Kompozycje i sposoby leczenia choroby trzewnej
IL234606B (en) Novel methods and composition for treatment of disease
DK2830645T3 (da) Neuregulin til anvendelse i behandling af perifær nervelæsion
DK2501381T3 (da) Behandling af atrieflimmer
DK2892556T3 (da) Sammensætninger og fremgangsmåder til behandling af sygdomme
BR112013014915A2 (pt) composição curativa e métodos de tratamento
BR112013003275A2 (pt) composição de tratamento oral
DK2928454T3 (da) Triaziner til behandling af protozosygdomme